(Q41326071)

29 September 2017

title

Intravenous immunoglobulin and mortality in pneumonia patients with septic shock: an observational nationwide study (English)

1 reference

29 September 2017

0 references

1 reference

4

1 reference

29 September 2017

3

Kiyohide Fushimi

1 reference

29 September 2017

Takashi Tagami

1

1 reference

29 September 2017

Hiroki Matsui

series ordinal

2

1 reference

29 September 2017

language of work or name

English

0 references

publication date

16 April 2015

1 reference

Clinical Infectious Diseases

29 September 2017

published in

1 reference

29 September 2017

volume

61

1 reference

29 September 2017

issue

3

1 reference

29 September 2017

page(s)

385-392

1 reference

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

Severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

Polyclonal immunoglobulin for treatment of bacterial sepsis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

Early therapy with IgM-enriched polyclonal immunoglobulin in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

The Japanese guidelines for the management of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

Use of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation after intestinal perforation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

Low-dose corticosteroid use and mortality in severe community-acquired pneumonia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

Effect of a selective neutrophil elastase inhibitor on mortality and ventilator-free days in patients with increased extravascular lung water: a post hoc analysis of the PiCCO Pulmonary Edema Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

Recombinant human soluble thrombomodulin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

Immortal time bias in pharmaco-epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

International study of the prevalence and outcomes of infection in intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

Drotrecogin alfa (activated) in adults with septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

The original sins of clinical trials with intravenous immunoglobulins in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

What is the best antimicrobial treatment for severe community-acquired pneumonia (including the role of steroids and statins and other immunomodulatory agents).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

Polyclonal intravenous immunoglobulin: an important additional strategy in sepsis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

Early-phase changes of extravascular lung water index as a prognostic indicator in acute respiratory distress syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV307

21 January 2018

Identifiers

DOI

10.1093/CID/CIV307

1 reference

29 September 2017

1 reference